Sun Pharma, the largest Indian pharma company by value, is set to strengthen its presence in the US skincare market. Last week, Sun’s Israeli subsidiary, Taro Pharma, received the US Food and......
It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......
Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known......